Journal profile · Immunology
Seminars in Immunology
ISSN 1044-5323 · eISSN 1096-3618 · Academic Press Inc. · ENGLAND · Bimonthly · Founded 1989
Seminars in Immunology: CAS Zone 2 · Medicine (2025 upgraded edition); impact factor 11.11; hybrid open access; APC about USD 4,370; median 100 days to acceptance (89 articles, last 24 months); community-reported acceptance: moderate; 58 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
Seminars in Immunology is published by Academic Press Inc. and is in Zone 2 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Immune Cell Function and Interaction, T-cell and B-cell Immunology and Immunotherapy and Immune Responses, together about 55.8% of its articles. Its main subfields are Immunology. (generated from OpenAlex topic counts and CAS ranking data)
Review articles in Seminars in Immunology are by invitation only.Seminars in Immunology is a review journal dedicated to keeping scientists informed of developments in the field of immunology on a topic by topic basis. Each issue is thematic in approach, devoted to an important topic of interest to immunologists, focusing on recent advances across a broad spectrum of research, from the molecular and cellular basis of the immune response to the possibilities for its manipulation. Every issue is edited by a guest editor, an internationally acknowledged expert in the field, and contains six to eight authoritative invited reviews on different aspects of the subject area. The aim of each issue is to provide a coordinated, readable, and lively review of a selected area, published rapidly to ensure currency. Topics Covered in Earlier Issues Include:• Mechanism of V(D)J rearrangement • Commitment to CD4 and CD8 lineages • Mechanisms of T cell help • Lessons from the LPR mouse • Phosphatidylinositol-linked molecules in T-cell activation
From the journal's Aims & Scope
Research area (LetPub): Immunology
Editor-in-chief G. KroemerPublisher website
Editorial board by country: none in mainland China; most named United States 12, Italy 7, France 6, United Kingdom 3, Canada 3 (36 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Immune Cell Function and InteractionImmunology and Microbiology22.1%
- T-cell and B-cell ImmunologyImmunology and Microbiology20.4%
- Immunotherapy and Immune ResponsesImmunology and Microbiology13.4%
- Immune Response and InflammationImmunology and Microbiology5.7%
- CAR-T cell therapy researchMedicine3.3%
- Immune cells in cancerImmunology and Microbiology3%
- Monoclonal and Polyclonal Antibodies ResearchMedicine2.7%
- IL-33, ST2, and ILC PathwaysImmunology and Microbiology2.5%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: yes
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 1
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 1 |
| Minor | Immunology | Zone 2 |
Top journal: yesReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 2
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 2 |
| Minor | Immunology | Zone 2 |
Top journal: noReview journal: yes
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 11.11LetPub ·
- Impact factor (publisher)
- 11.5Publisher website ·
- CiteScore 2026-06
- 16.5LetPub ·
- CiteScore (publisher)
- 16.5Publisher website ·
- SJR 2026-06
- 3.62LetPub ·
- SNIP 2026-06
- 1.68LetPub ·
- h-index
- 114LetPub ·
- h-index
- 177OpenAlex ·
- i10-index
- 1,483OpenAlex ·
- 2-year mean citedness
- 6.81OpenAlex ·
- Self-citation rate
- 1.7%LetPub ·
- Share of gold OA articles
- 40.96%LetPub ·
Volume
- Articles per year
- 52LetPub ·
Articles by year OpenAlex count · 1,840 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 38 | 15 | 30 |
| 2025 | 58 | 34 | 416 |
| 2024 | 33 | 21 | 433 |
| 2023 | 93 | 65 | 3,244 |
| 2022 | 52 | 33 | 1,746 |
| 2021 | 74 | 41 | 3,318 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with PubMed · to
100 daysMedian, submission to acceptance · P25–P75 63 days – 162 days
- Acceptance to online
- median 10 days (88 articles)
- Submission to online
- median 112 days
- Sample
- 89 articles with submission and acceptance dates (97 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 7 daysPublisher website ·
- First decision after review
- 60 daysPublisher website ·
- Submission to acceptance
- 85 daysPublisher website ·
- Acceptance to publication
- 8 daysPublisher website ·
- Peer review
- Single anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,370 / EUR 4,090 / GBP 3,500 / JPY 542,010 | — | — | |
| Publisher website | USD 4,270 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare1 items from the author guidelines
- Abstract
- ≤ 250 words
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Publication ethics, License & copyright, Open access, Peer review, Preprints
- AI use Declaration of generative AI use
Authors must declare the use of generative AI tools in the manuscript preparation process upon submission of the paper.Generative AI and AI-assisted technologies (“AI tools”) have been rapidly adopted in research and scholarly publishing, offering significant benefits while requiring clear standards for responsible and transparent use.Authors preparing a manuscript for this journal may use AI tool…
Source ↗Publisher website ·- Authorship Group authorship
Submission declaration: work not published previously except preprint/abstract/lecture/thesis/registered report; not under consideration elsewhere; approved by all authors; not published elsewhere without consent. Model summary
Group authorship refers to the attribution of an article to a defined and named group of authors whose members have contributed to the work. Examples include research consortia, clinical trial groups, collaborative networks, task forces or working groups, expert panels or consensus groups, and participatory research groups. Group authorship must be declared on the title page at submission. When av…
Source ↗Publisher website ·- Conflicts of interest Declaration of competing interests
All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence or bias their work. Examples of potential competing interests include:EmploymentConsultanciesStock ownershipHonorariaPaid expert testimonyPatent applications or registrationsGrants or any other fundingAffiliation with the journal as an Editor or Advisory Board …
Source ↗Publisher website ·- Publication ethics
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy. Model summary
Authors must follow ethical guidelines stated in Elsevier's Publishing Ethics Policy.
Source ↗Publisher website ·- License & copyright License options
Authors will be offered open access user license options which will determine how you, and third parties, can reuse your open access article. We advise that you review these options and any funding body license requirements before selecting a license option.
Source ↗Publisher website ·- Open access Open access
We refer you to our open access information page to learn about open access options for this journal.
Source ↗Publisher website ·- Peer review Peer review
Single anonymized review process; submissions initially assessed by editors; if suitable, sent to a minimum of two reviewers; decision made by editors. Model summary
This journal follows a single anonymized review process. Your submission will initially be assessed by our editors. If your submission is deemed suitable, it will typically be sent to be reviewed by a minimum of two reviewers for an independent expert assessment of the scientific quality. The decision as to whether your article is accepted or rejected for publication will be made by our editors.Re…
Source ↗Publisher website ·- Preprints Preprints
Preprint sharing allowed in line with Elsevier's article sharing policy; does not count as prior publication. Model summary
Preprint sharingAuthors may share preprints in line with Elsevier's article sharing policy. Sharing preprints, such as on a preprint server, will not count as prior publication.We advise you to read our policy on multiple, redundant or concurrent publication.
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Academic Press Inc.
- Country or region
- ENGLAND
- Language
- English
- Frequency
- Bimonthly
- Founded
- 1989
- ISSN
- 1044-5323
- Electronic ISSN
- 1096-3618
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗Publisher website
- Special issues ↗Publisher website
FAQ
Frequently asked questions about Seminars in Immunology
What CAS zone is Seminars in Immunology in?
In the 2025 upgraded edition of the CAS Journal Ranking, Seminars in Immunology is in Zone 2 of Medicine, and in Zone 2 of the minor category Immunology. In the 2026 Xinrui edition it is in Zone 1 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of Seminars in Immunology?
The latest impact factor listed by LetPub is 11.11; CiteScore 16.5, h-index 177.
How long does peer review take at Seminars in Immunology?
Based on the dates recorded on 89 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 100 days (interquartile range 63–162 days); the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
Where are the editorial board members of Seminars in Immunology based?
Of the 36 board members whose country the journal's board page names, none are in mainland China; the countries named most often are United States (12), Italy (7) and France (6). Counted from the institutions listed on the board page; for reference only.
Which databases index Seminars in Immunology?
According to LetPub and DOAJ records, Seminars in Immunology is indexed in SCIE and Scopus.
Is Seminars in Immunology open access, and what is the APC?
Seminars in Immunology is a hybrid journal. For open-access publication: APC about USD 4,370.
Sources and updates
The facts on this page come from LetPub, Publisher website, OpenAlex; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-25). Last updated: .